Suchergebnisse - "Isakova-Sivak, Irina"

PubPharm (10)

1

Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza

enthalten in: Expert review of vaccines | 2022

von Stepanova, E. | Isakova-Sivak, I. | Rudenko, L.

2

Influenza vaccine : progress in a vaccine that elicits a broad immune response

enthalten in: Expert review of vaccines | 2021

von Isakova-Sivak, I. | Stepanova, E. | Mezhenskaya, D. | +5

3

Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines

enthalten in: Expert review of vaccines | 2020

von Isakova-Sivak, I. | Grigorieva, E. | Rudenko, L.

4

Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine

enthalten in: Expert review of vaccines | 2018

von Korenkov, D. | Isakova-Sivak, I. | Rudenko, L.

5

Tackling a novel lethal virus : a focus on H7N9 vaccine development

enthalten in: Expert review of vaccines | 2017

von Isakova-Sivak, I. | Rudenko, L.

6

Cold-adapted influenza viruses as a promising platform for viral-vector vaccines

enthalten in: Expert review of vaccines | 2016

von Isakova-Sivak, I. | Tretiak, T. | Rudenko, L.

7

Reassortant viruses for influenza vaccines : is it time to reconsider their genome structures?

enthalten in: Expert review of vaccines | 2016

von Isakova-Sivak, I. | Korenkov, D. | Rudenko, L.

8

Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus

enthalten in: Expert review of vaccines | 2015

von Rudenko, L. | Isakova-Sivak, I.

9

Safety, immunogenicity and infectivity of new live attenuated influenza vaccines

enthalten in: Expert review of vaccines | 2015

von Isakova-Sivak, I. | Rudenko, L.

10

H7N9 : can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?

enthalten in: Expert review of vaccines | 2014

von Rudenko, L. | Isakova-Sivak, I. | Rekstin, A.

1
[1]